Cell Signaling Technology

Toll-like Receptor 9 Antibody

#2254 · $317

66
Evidence Score · Well-Established
Used by 258 independent labs across 279 papers. How we score this →
100
Citing papers
18.1k
Combined citations
Supplier page Find this product

Research areas

RNA modifications and cancer15Cancer-related molecular mechanisms research13Cancer-related gene regulation10Immune cells in cancer8MicroRNA in disease regulation8Circular RNAs in diseases6Cancer Cells and Metastasis6Extracellular vesicles in disease5

Papers citing this product

1
METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner
Molecular Cancer·2019·746 cit.·DOI
2
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
Journal of Thoracic Oncology·2015·682 cit.·DOI
3
RETRACTED ARTICLE: RNA m6A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail
Nature Communications·2019·555 cit.·DOI
4
METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST
Molecular Cancer·2020·539 cit.·DOI
5
Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells
Journal of Clinical Investigation·2001·434 cit.·DOI
6
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
Nature Immunology·2021·422 cit.·DOI
7
Human Papillomaviruses Activate the ATM DNA Damage Pathway for Viral Genome Amplification upon Differentiation
PLoS Pathogens·2009·394 cit.·DOI
8
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
Molecular Cancer·2020·377 cit.·DOI
9
Bone Morphogenetic Protein-2 Stimulates Runx2 Acetylation
Journal of Biological Chemistry·2006·343 cit.·DOI
10
Twelve Weeks of Sprint Interval Training Improves Indices of Cardiometabolic Health Similar to Traditional Endurance Training despite a Five-Fold Lower Exercise Volume and Time Commitment
PLoS ONE·2016·341 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
Toll-like Receptor 9 (D2C9) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology66$152,351100
Toll-like Receptor 9 (D9M9H) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology66$161,38475
Toll-like Receptor 9 (F4R3J) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology66$161,3764

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.